Sabinsa says the agency found a minor, now-corrected issue at one of the facilities.
FDA has inspected five of Sabinsa Corp.’s SAMI Labs manufacturing facilities in India, finding minor issue with just one of those facilities, as Sabinsa explains:
“The issue involved a polyliner becoming tangled in the conveyer belts leading to the extraction chamber; corrective action included changing to HDPE bags without lining and improving hopper and mesh at the point of feeding raw material into the extraction equipment.”
The inspected facilities were located in Kunigal, Nelamangala, and Dobaspet (Karnataka), and Genome Valley, Hyderabad.
The Nutritional Outlook Podcast Episode 33: Keeping up with contract manufacturing
July 26th 2024Nutritional Outlook talks to Lauren Samot, commercial innovation leader, and Blayney McEneaney, sales executive at Vitaquest International, about trends within the contract manufacturing space, and the ways in which contract manufacturers like Vitaquest keep up with the market and differentiate themselves from the competition.